Corrigendum to “Reversible heterolytic C–H cleavage by intramolecular C–H activation at diazabutadiene ligands at iridium” [J. Mol. Catal. A 189 (2002) 23–32]

Lysosome‐targeted potent half‐sandwich iridium(III) α‐diimine antitumor complexes

“…Reactions between [Cp x IrCl 2 ] 2 and a number of aryl‐substituted dab (ArN═CR─CR═NAr (R = Me)) proceeded in the anticipated fashion to afford the [Cp x Ir (dab)Cl]PF 6 species in good yields. Only complex 4A has been previously reported; the other fourteen complexes are newly synthesized compounds. The prepared half‐sandwich Ir(III) complexes and synthetic route are summarized in Figure and Scheme , respectively.…”

Half-sandwich iridium complexes—Synthesis and applications in catalysis

“…Thus, the reaction of [Cp*IrCl 2 ] 2 with arylsubstituted diazabutadienes in methanol led to the η 2 -C,N iridium complexes 58 through C-H activation of the methyl group on the ethylene bridge of the diimine (Table 5, entry 4); the anticipated Cp*Ir(η 2 -N,N-diimine) complex was not formed [41]. Reaction of 2-diphenylphosphinobenzaldehyde and [Cp*IrCl 2 ] 2 resulted in a neutral acyl complex 59, through C-H activation of the aldehyde (Table 5, entry 5) [42].…”

Catalytic Processes Involving Dihydrogen Complexes and Other Sigma-bond Complexes

“…a r-complex such as M + -CH 4 bears an electronic relationship to CH þ 5 and also a strong analogy to the isobutane-HZSM-5 complex [134] described above. A clear example of reversible, intramolecular heterolytic C-H cleavage at diazabutadiene ligands on iridium(III) has recently been reported [144]. Also, calculations support a heterolytic mechanism in scheme 12 over one based on C-H oxidative addition [141].…”